National Registry of Drug Industry CME Will Be Proposed By Sen. Kohl
Executive Summary
Legislation to create a national registry of pharmaceutical company funding for continuing medical education and other support to physicians is being drafted by Sen. Herb Kohl, D-Wis
You may also be interested in...
As Drug Marketing Laws Proliferate In States, PhRMA Rejects Federal Option
State laws to restrict how pharmaceutical companies market their products to physicians are not yet so burdensome that industry is ready to support a federal scheme, Pharmaceutical Research and Manufacturers of America VP for Government Affairs Jan Faiks told the Food and Drug Law Institute's advertising and promotion conference Sept. 17
As Drug Marketing Laws Proliferate In States, PhRMA Rejects Federal Option
State laws to restrict how pharmaceutical companies market their products to physicians are not yet so burdensome that industry is ready to support a federal scheme, Pharmaceutical Research and Manufacturers of America VP for Government Affairs Jan Faiks told the Food and Drug Law Institute's advertising and promotion conference Sept. 17
States Boost Oversight Of Rx Marketing; In Vt., Reps Must Discuss “Alternatives”
As of next year, pharmaceutical companies will face tougher restrictions on their marketing activities in Vermont and Nevada, and naturally, the climate in New England will be chillier: The Vermont bill is the more rigorous and comprehensive measure